Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann N Y Acad Sci. 2003 Apr;986:702-7.

Myocardial Na,K-ATPase and digoxin therapy in human heart failure.

Author information

1
Medical Department B, The Heart Center, Rigshospitalet, University of Copenhagen, Denmark. kjeldsen@rh.dk

Abstract

The specific binding of digitalis glycosides to the Na,K-ATPase is used as a tool for Na,K-ATPase quantification with high accuracy and precision. In myocardial biopsies from patients with heart failure, total Na,K-ATPase concentration is decreased, and the decrease in Na,K-ATPase concentration correlates with a decrease in heart function. During digitalization, a fraction of remaining pumps are occupied by digoxin. No evidence for an endogenous digitalis-like factor of any clinical importance was obtained. It is recommended that digoxin be administered to heart failure patients who still have dyspnea after institution of mortality-reducing therapy.

PMID:
12763921
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center